Neutrogena Scalp Therapy Anti-Dandruff Scalp Build-Up Control

Manufacturer
Kenvue Brands LLC
Effective date
2025-06-04
Label type
HUMAN OTC DRUG LABEL
Version
5
Source
full-release
Hydrated at
2026-06-01 01:02:25

Label at a glance#

ProductNeutrogena Scalp Therapy Anti-Dandruff Scalp Build-Up Control
Active ingredientSALICYLIC ACID
Label structure11 sections

Dosage and administration

For best results, use at least twice a week or as directed by a doctor. Wet hair thoroughly. Massage shampoo into the scalp. Lather, leaving on your hair and scalp for a few minutes. Rinse and repeat.

Storage and handling

Store at room temperature.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid (2.5%)

Purposes

OTC - PURPOSE SECTION

Anti-dandruff, Anti-seborrheic dermatitis, Anti-psoriasis

Use

INDICATIONS & USAGE SECTION

Controls the symptoms of dandruff, seborrheic dermatitis and psoriasis.

Warnings

WARNINGS SECTION

For external use only.

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have a condition that covers a large area of the body.

OTC - WHEN USING SECTION

When using this product avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.

OTC - STOP USE SECTION

Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

For best results, use at least twice a week or as directed by a doctor.

  • Wet hair thoroughly.
  • Massage shampoo into the scalp.
  • Lather, leaving on your hair and scalp for a few minutes.
  • Rinse and repeat.

Other information

STORAGE AND HANDLING SECTION

Store at room temperature.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water, Sodium C14-16 Olefin Sulfonate, Cocamidopropyl Betaine, Sodium Chloride, Polyquaternium-22, Sodium Citrate, Hexylene Glycol, Sodium Lauroyl Sarcosinate, , Linoleamidopropyl PG-Dimonium Chloride Phosphate, Citric Acid, Sodium Hydroxide

Questions?

OTC - QUESTIONS SECTION

Call 800-256-4247or 215-273-8755 (collect) or visit www.neutrogena.com

SPL UNCLASSIFIED SECTION

Distributed by:
Kenvue Brands LLC
Summit, NJ 07901

PRINCIPAL DISPLAY PANEL - 354 mL Bottle Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NEUTROGENA

Scalp Therapy TM

Anti-Dandruff

MEDICATED

SCALP BUID-UP CONTROL

2.5% SALICYLIC ACID

SHAMPOO

with apple cider vinegar

Neutrogena ®

DERMATOLOGIST RECOMMENDED BRAND

12 FL OZ (354 mL)

Neutrogena_1Neutrogena_1

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2586423salicylic acid 2.5 % Medicated ShampooPSN5
2586423salicylic acid 25 MG/ML Medicated ShampooSCD5
2586423salicylic acid 2.5 % Medicated ShampooSY5

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69968-0724-1Neutrogena Scalp Therapy Anti-Dandruff Scalp Build-Up Control354 mL in 1 BOTTLE, PLASTICSHAMPOO3545

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69968-072469968-0724-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
36b9648e-19d6-09aa-e063-6294a90ab3eeca4b6afd-036d-7cc3-e053-2995a90acedd2025-06-04WarningsExact identifier
spl id: 36b9648e-19d6-09aa-e063-6294a90ab3ee
spl set id: ca4b6afd-036d-7cc3-e053-2995a90acedd

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.